VTGN ▼ -2.6% - Vistagen Therapeutics, Inc.
$VTGN - Vistagen Reports Positive Findings Supporting Fasedienol’s Potential in Very Severe Social Anxiety Disorder
24-SEP-2026 07:00 AM ET
Share this post
More filings for $VTGN
VTGN ▲ +13.0% - Vistagen Therapeutics, Inc.Sep 22, 2026VTGN - Vistagen Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026VTGN - Vistagen Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026VTGN - Vistagen Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $VTGN filing history →💬 Comments
Loading comments…
Leave a comment